Emfo, LLC
- SEC CIK
- 0001859434
- Latest filing
- Jul 26, 2024
BMRN holding history
Biomarin Pharmaceutical Inc in every 13F filed by Emfo, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BMRN overviewAll 13F holders of BMRNFull Q2 2024 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −1,085−100.0% | Sold out | Holders |
| Q4 2022 | 1,085 | $112.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 1,085 | $92.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 1,085 | $90.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 1,085 | $84.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 1,085 | $96.0K | 0.1% | −52−4.6% | Reduced | Holders |
| Q3 2021 | 1,137 | $88.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 1,137 | $95.0K | 0.1% | – | No prior filing | Holders |